Executive director, European Biopharmaceuticals Enterprises, EBE (replaced Marc de Garidel, President European Biopharmaceuticals Enterprises, EBE)
Alexandre Delacoux is European Biopharmaceutical Enterprises (EBE) Executive Director since January 2011. With over 20 years professional experience in European and international public affairs, Alexandre Delacoux brings to EBE a unique combination of experience in the life sciences sector, European and international policy advocacy and managerial skills. EBE is the Brussels-based European trade association that represents biopharmaceutical companies of all sizes in Europe. It has 60 member companies engaged in the research, development and manufacturing of innovative medicinal products using biotechnology, with a large representation of European small and medium size businesses. EBE also operates as the biotechnology arm of EFPIA, the European Pharmaceutical Industry Federation.